Skip to content
Home/Companies/Healthcare/Corvidia Therapeutics
CT

Corvidia Therapeutics

Healthcare·US·Exited 2020·Held 2yr

Corvidia Therapeutics is a healthcare company, headquartered in United States.

Entry
2018
Hold
2yr
Exit
2020
Est. EV
–

Who owns Corvidia Therapeutics?

Corvidia Therapeutics was owned by Andera Partners through BioDiscovery 5 (2017 vintage) from 2018 to 2020, exited via Trade Sale. Across its history, Corvidia Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Andera Partners
Most recent investor
Andera Partners
BioDiscovery 5 · 2017 · VC
2 ownership periods · full history below

Key facts

HQUnited States
SectorHealthcare
Key takeaways
  • ·Fully exited in 2020.
  • ·Average hold across 2 realized cycles: 3 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2020 to .
Co-invest · 2 holders · 2016 · 2020
Sofinnova Partners
Sofinnova PartnersExited 2020
2016 · 2020 · Sofinnova Capital VIII · 2015 · Life Sciences VC
Trade Sale · to
MOIC
–
Andera Partners
Andera PartnersExited 2020
2018 · 2020 · BioDiscovery 5 · 2017 · VC
Trade Sale · to
MOIC
–

More from BioDiscovery 5

Other portfolio companies in the same fund.

Amolyt Pharma
Exited 2024
HealthcareFrance· 2021
to
Evommune
Exited 2025
HealthcareFrance· 2021
to
Nyxoah
Active
HealthcareBelgium· 2020
AgoMab
Exited 2026
HealthcareFrance· 2019
to
AM Pharma
Active
HealthcareNetherlands· 2019
Arvelle
Exited 2021
HealthcareSwitzerland· 2019
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings